Pergolide:: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS).: Longterm follow up on pergolide -: Short communication

被引：26

作者：

Staedt, J ^{[1
]}

Hünerjäger, H ^{[1
]}

Rüther, E ^{[1
]}

Stoppe, G ^{[1
]}

机构：

[1] Univ Gottingen, Dept Psychiat, D-37075 Gottingen, Germany

来源：

JOURNAL OF NEURAL TRANSMISSION | 1998年 / 105卷 / 2-3期

关键词：

restless legs syndrome; RLS; nocturnal myoclonus syndrome; NMS; pergolide; longterm treatment;

D O I：

10.1007/s007020050055

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Pergolide has proven significantly superior to L-dopa plus peripheral decarboxylase inhibitor in short-term therapy of RLS/NMS. We now first present long-term follow-up sleep data showing its lastingly good effects after averagely 517 treatment days.

引用

页码：265 / 268

页数：4

共 50 条

[1] Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide
J. Staedt
H. Hünerjäger
E. Rüther
G. Stoppe
Journal of Neural Transmission, 1998, 105 : 265 - 268
[2] Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa
J. Staedt
F. Waβmuth
U. Ziemann
G. Hajak
E. Rüther
G. Stoppe
Journal of Neural Transmission, 1997, 104 : 461 - 468
[3] Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa
Staedt, J
Wassmuth, F
Ziemann, U
Hajak, G
Ruther, E
Stoppe, G
JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (4-5) : 461 - 468
[4] Treatment of the restless legs syndrome with pergolide
Trenkwalder, C
Winkelmann, J
Stiasny, K
Wetter, TC
Oertel, WH
NEUROLOGY, 1997, 48 (03) : 54005 - 54005
[5] The safety of pergolide in the treatment of restless legs syndrome RLS: Results of a randomized long-term multicenter trial of pergolide in the treatment of RLS
Hundemer, H
Trenkwalder, C
Lledo, A
Quail, D
Rubin, M
Swieca, J
Polo, O
Wetter, T
Strambi, L
deGroen, J
SLEEP, 2001, 24 : A17 - A17
[6] The safety of pergolide in the treatment of restless legs syndrome (RLS): Results of a randomized long-term multicenter trial of pergolide in the treatment of RLS
Hundemer, HP
Trenkwalder, C
Lledo, A
Quail, D
Rubin, M
Swieca, J
Polo, O
Wetter, TC
Strambi, LF
deGroen, HJ
NEUROLOGY, 2001, 56 (08) : A20 - A20
[7] Low dosage of pergolide in the treatment of restless legs syndrome
Noel, S
Korri, H
Vanderheyden, JE
ACTA NEUROLOGICA BELGICA, 1998, 98 (01) : 52 - 53
[8] Efficacy of pergolide in treatment of restless legs syndrome - The PEARLS Study
Trenkwalder, C
Hundemer, HP
Lledo, A
Swieca, J
Polo, O
Wetter, TC
Ferini-Strambi, L
de Groen, H
Quail, D
Brandenburg, U
NEUROLOGY, 2004, 62 (08) : 1391 - 1397
[9] A polysomnographic, controlled study of pergolide in the treatment of restless legs syndrome
Wetter, TC
Stiasny, K
Winkelmann, J
Buhlinger, A
Brandenburg, U
Peter, JH
Medori, R
Rubin, M
Oertel, WH
Trenkwalder, C
NEUROLOGY, 1998, 50 (04) : A69 - A69
[10] NIGHTLY MYOCLONUS SYNDROME (NMS) AND RESTLESS LEGS SYNDROME (RLS) - REVIEW AND CASE-REPORT
STAEDT, J
STOPPE, G
KOGLER, A
MUNZ, DL
HAJAK, G
STAEDT, U
RIEMANN, H
RUTHER, E
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1994, 62 (03) : 88 - 93

← 1 2 3 4 5 →